

Is Amcinonide still in shortage in 2026? Get the latest update on availability, pricing, and what patients can do to find Amcinonide in stock.
If you rely on Amcinonide to manage a chronic skin condition, the past few years have probably felt like a guessing game at the pharmacy. Will they have it? Will they not? How long will I have to wait?
In this update, we'll cover the current status of Amcinonide availability in 2026, explain why supply issues continue, and give you actionable steps to get the medication you need.
As of early 2026, Amcinonide is not officially listed on the FDA's drug shortage database. That means the federal government doesn't classify it as being in a formal shortage.
However, that doesn't tell the whole story. Many patients still report difficulty finding Amcinonide at their local pharmacies. The issue isn't a sudden supply disruption — it's a long-term pattern of limited availability caused by structural factors in how this medication is produced and distributed.
Think of it this way: the FDA tracks shortages caused by major manufacturing disruptions. Amcinonide's availability problems are more of a slow simmer — not enough manufacturers, not enough pharmacy stocking, and not enough attention to a niche medication.
Several factors contribute to the ongoing difficulty in finding Amcinonide:
The brand-name version, Cyclocort, was discontinued years ago when Pfizer acquired Wyeth. Without a branded product driving demand and marketing, Amcinonide became a generic-only medication with less visibility and less consistent supply.
Only a small number of generic pharmaceutical companies produce Amcinonide. When even one manufacturer experiences production delays, the effects ripple across the entire market. Compare this to medications like Triamcinolone, which has many generic manufacturers and is almost always in stock.
Dermatologists have several high-potency topical steroids to choose from. Because Amcinonide is prescribed less frequently than alternatives like Fluocinonide or Betamethasone, pharmacies may not keep it on hand. For a deeper dive into why, read our article on why Amcinonide is so hard to find.
Cost remains a significant barrier for many patients:
Without insurance or a discount coupon, Amcinonide is one of the more expensive topical steroids on the market. This high cost can make it even harder for patients who are already struggling with availability issues.
For tips on reducing your out-of-pocket costs, check out our guide on how to save money on Amcinonide.
There haven't been any new branded formulations of Amcinonide introduced in recent years. The medication landscape for topical corticosteroids has remained relatively stable, with the same generics available.
However, the broader dermatology market has seen growth in non-steroidal alternatives for conditions like eczema and psoriasis. Medications like Dupixent (dupilumab), Eucrisa (crisaborole), and JAK inhibitors offer different mechanisms of action. These are typically reserved for moderate-to-severe cases and may be worth discussing with your dermatologist if topical steroids aren't meeting your needs.
For patients who specifically need a topical corticosteroid, the best bet remains finding a pharmacy with Amcinonide in stock or switching to a similar-potency alternative.
Here are the most effective strategies for locating Amcinonide in 2026:
For a complete walkthrough, see our guide on how to find Amcinonide in stock near you.
Amcinonide isn't in an official FDA shortage, but that doesn't mean it's easy to find. Limited manufacturers, a discontinued brand, and high costs continue to create challenges for patients in 2026. The key is to be proactive: use tools like Medfinder, explore all pharmacy options, and talk to your doctor about alternatives if needed.
Your skin condition deserves treatment. Don't let supply chain issues stand in your way.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.